Arjen Sutterland
Arjen Sutterland
Department Early Psychosis, AMC, Amsterdam
Verified email at
Cited by
Cited by
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis
AL Sutterland, G Fond, A Kuin, MWJ Koeter, R Lutter, T Gool, R Yolken, ...
Acta Psychiatrica Scandinavica 132 (3), 161-179, 2015
Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1–12.5 years
JM Vermeulen, G van Rooijen, MPJ van de Kerkhof, AL Sutterland, ...
Schizophrenia bulletin 45 (2), 315-329, 2019
Incidence rates and risk factors of bipolar disorder in the general population: a population‐based cohort study
JS Kroon, TD Wohlfarth, J Dieleman, AL Sutterland, JG Storosum, ...
Bipolar disorders 15 (3), 306-313, 2013
Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: a systematic review and meta-analysis
M Pierce, A Sutterland, EM Beraha, K Morley, W van den Brink
European Neuropsychopharmacology 28 (7), 795-806, 2018
In vivo (R)-[11 C] PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis
TF Van Der Doef, LD De Witte, AL Sutterland, E Jobse, M Yaqub, ...
NPJ schizophrenia 2 (1), 1-5, 2016
Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study
AL Sutterland, J Dieleman, JG Storosum, BAC Voordouw, J Kroon, ...
Social psychiatry and psychiatric epidemiology 48 (9), 1357-1365, 2013
Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents – a systematic review and meta-analysis
AL Sutterland, A Kuin, B Kuiper, T van Gool, M Leboyer, G Fond, ...
Psychological medicine 49 (10), 1608-1623, 2019
Early-life metal exposure and schizophrenia: A proof-of-concept study using novel tooth-matrix biomarkers
A Modabbernia, E Velthorst, C Gennings, L De Haan, C Austin, ...
European Psychiatry 36, 1-6, 2016
Advanced glycation end products in recent-onset psychosis indicate early onset of cardiovascular risk
JM Hagen, AL Sutterland, MW Koeter, R Lutter, D Cohen, L de Haan
The Journal of clinical psychiatry 78 (9), 1395-1401, 2017
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
N Çakici, AL Sutterland, BWJH Penninx, VA Dalm, L de Haan, ...
Brain, behavior, and immunity 88, 547-558, 2020
Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders
AL Sutterland, MT Blom, K Ladee, JJM Lubbers, D Cohen, L de Haan, ...
Schizophrenia research 210, 59-65, 2019
Protocol Across study: longitudinal transdiagnostic cognitive functioning, psychiatric symptoms, and biological parameters in patients with a psychiatric disorder
DH Nieman, UY Chavez-Baldini, NC Vulink, DJA Smit, G van Wingen, ...
BMC psychiatry 20, 1-9, 2020
The association between antibodies to neurotropic pathogens and bipolar disorder
GJLJ Snijders, HC van Mierlo, MP Boks, MJH Begemann, AL Sutterland, ...
Translational psychiatry 9 (1), 1-13, 2019
Treating prolactinoma and psychosis: medication and cognitive behavioural therapy
DH Nieman, AL Sutterland, J Otten, HE Becker, ML Drent, ...
Case Reports 2011, bcr0720103185, 2011
Delusional infestation, a therapeutic challenge
YQ Jagt, AL Sutterland, JH Meijer, MS Oudijn, PM Kemperman, NC Vulink, ...
Nederlands tijdschrift voor geneeskunde 158, A7548-A7548, 2014
Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study
JM Hagen, AL Sutterland, F Schirmbeck, DM Cohn, A Lok, HL Tan, ...
Journal of Affective Disorders 275, 230-237, 2020
Toxoplasma gondii: Potential therapeutic applications in psychiatry
G Fond, A Sutterland
L'information psychiatrique 92 (10), 809-814, 2016
Transdiagnostic Exploration of the Association of Toxoplasma Gondii with Psychiatric Disorders. a Systematic Review and Meta Analysis
A Sutterland, G Fond, A Kuin, M Koeter, R Lutter, T Van Gool, R Yolken, ...
European Psychiatry 30 (S1), 1-1, 2015
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a …
N Çakici, AL Sutterland, BWJH Penninx, L De Haan, NJM Van Beveren
Psychological medicine 51 (4), 538-549, 2021
Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis
JM Hagen, AL Sutterland, T Liefers, F Schirmbeck, DM Cohn, A Lok, ...
Journal of Affective Disorders 282, 1082-1089, 2021
The system can't perform the operation now. Try again later.
Articles 1–20